Key excerpts: PhRMA submits comments to keep the six protected classes protected

Earlier this month, PhRMAsubmitted comments to CMS regarding the Part D Payment Modernization Model Request for Applications (RFA) for calendar year 2022. This RFA was released on January 19, 2021 – the last full day of the Trump Administration. Since the inception of the Medicare Part D program, PhRMA has supported the Part D policy of protecting certain drug categories or classes in which patients require access to a broad range of treatments without unreasonable delay. The protected clas s policy offers valuable protections for vulnerable patients and PhRMA strenuously opposes any weakening of the formulary protections for Part D beneficiaries.

Source: The Catalyst - February 19, 2021 Category: Pharmaceuticals Authors: Tom Wilbur Tags: Part D Medicare Source Type: news